CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 47 (11) , 2371-2379
Abstract
Chronic lymphocytic leukemia (CLL) follows a variable clinical course which is difficult to predict at diagnosis. We assessed somatic mutation (SHM) status, CD38 and ZAP-70 expression in 87 patients (49 male, 38 female) with stage A CLL and known cytogenetic profile to compare their role in predicting disease progression, which was assessed by the treatment free interval (TFI) from diagnosis. Sixty (69%) patients were SHM+, 24 (28%) were CD38+ and ten (12%) were ZAP-70+. The median TFI for: (i) SHM + versus SHM− patients was 124 versus 26 months; hazard ratio (HR) = 3.6 [95% confidence interval (CI) = 1.8 – 7.3; P = 0.001]: (ii) CD38− versus CD38+ patients was 120 versus 34 months; HR = 2.4 (95% CI = 1.4 – 5.3; P = 0.02); and (iii) ZAP70− versus ZAP70+ was 120 versus 16 months; HR = 3.4 (95% CI = 1.4 – 8.7; P = 0.01). SHM status and CD38 retained prognostic significance on multivariate analysis whereas ZAP-70 did not. We conclude that ZAP-70 analysis does not provide additional prognostic information in this group of patients.Keywords
This publication has 30 references indexed in Scilit:
- ZAP-70 expression and prognosis in chronic lymphocytic leukaemiaThe Lancet, 2004
- The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progressionBlood, 2003
- Relationship between p53 dysfunction, CD38 expression, andIgVH mutation in chronic lymphocytic leukemiaBlood, 2002
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaLeukemia, 2002
- Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic LeukemiaJournal of Experimental Medicine, 2001
- CD38 Expression Correlates with Adverse Biological Features and Predicts Poor Clinical Outcome in B-Cell Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2001
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Human Severe Combined Immunodeficiency Due to a Defect in ZAP-70, a T Cell Tyrosine KinaseScience, 1994
- Sequential Interactions of the TCR with Two Distinct Cytoplasmic Tyrosine KinasesScience, 1994
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981